According to Scribe Therapeutics's latest financial reports the company's current earnings are โฌ51.17 Million. In 2025 the company made an earning of -โฌ18.32 Million, an increase over its 2024 earnings that were of -โฌ30.37 Million. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.